<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The diabetic phenotype is complex, requiring elucidation of key initiating defects </plain></SENT>
<SENT sid="1" pm="."><plain>Recent research has shown that diabetic myotubes express a primary reduced <z:chebi fb="0" ids="27093">tricarboxylic acid</z:chebi> (<z:chebi fb="6" ids="30956">TCA</z:chebi>) cycle flux </plain></SENT>
<SENT sid="2" pm="."><plain>A reduced <z:chebi fb="6" ids="30956">TCA</z:chebi> cycle flux has also been shown both in insulin resistant offspring of T2D patients and exercising T2D patients in vivo </plain></SENT>
<SENT sid="3" pm="."><plain>This review will discuss the latest advances in the understanding of the molecular mechanisms regulating the <z:chebi fb="6" ids="30956">TCA</z:chebi> cycle with focus on possible underlying mechanism which could explain the impaired <z:chebi fb="6" ids="30956">TCA</z:chebi> flux in insulin resistant human skeletal muscle in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>A reduced <z:chebi fb="6" ids="30956">TCA</z:chebi> is both a marker and a maker of the diabetic phenotype </plain></SENT>
</text></document>